# Evaluating Bronchodilator Response in Patients With Bronchiectasis

> **NCT05932316** · NA · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 96 (estimated)

## Conditions studied

- Bronchiectasis
- Cystic Fibrosis
- Primary Ciliary Dyskinesia
- Primary Immune Deficiency
- Bronchiolitis Obliterans

## Interventions

- **DIAGNOSTIC_TEST:** spirometry
- **DRUG:** Salbutamol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT05932316
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-20
- **Primary completion:** 2024-04
- **Final completion:** 2024-12
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2023-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05932316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05932316, "Evaluating Bronchodilator Response in Patients With Bronchiectasis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05932316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*